Journal article · 2020 · Open access

Unfolding Remedial Targets for Alzheimer's Disease

M. Tamilselvan, T. Tamilanban, V. Chitra

Research Journal of Pharmacy and Technology, 13(6), 3021 · Published 1 January 2020 · DOI 10.5958/0974-360x.2020.00534.x

Read the free full textCite this paper

In brief

“Unfolding Remedial Targets for Alzheimer's Disease” is a 2020 journal article by M. Tamilselvan and 2 co-authors, published in Research Journal of Pharmacy and Technology. OpenAlex counts 10 citations as of 15 November 2026, which puts it in the top 9% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Research Journal of Pharmacy and Technology.

Citations
10
Most cited in
2025 (4)
Field-weighted impact
0.27
Authors
3

Abstract

Dementia also termed as memory loss is due to the functional impairment of behavior and cognition in people aged 65 years and above. Alzheimer's disease (AD) is the most occurring neurodegenerative disorder around the globe and its estimated that about 47 million people are affected by this disease and is expected to increase to 62% by the end of 2030. It is characterized by the intracellular neuro-fibrillary tangles, extracellular amyloid plaques, and deficiency cholinergic neurons and cholinergic transmission. Alzheimer's disease is due to many reasons. The early-onset Alzheimer's disease, an uncommon form of disease, which pursues an autosomaldominant model in most of cases with mutations recognized in amyloid precursor protein (APP), presenilin (PS) 1 and 2. The late-onset Alzheimer's disease, an erratic form of disease, which affects over 90% of patients with different genetic makeup and the associated risk factors are studied by different genetic studies and bioinformatic methods. These findings gave us deeper insights about the pathogenesis of Alzheimer's disease and also in the advancement of newer therapeutic pathways and clinical trial designs. Presently available drugs are gives only symptomatic relief to the patients such as reversible acetylcholinestrase inhibitors Donepezil, Rivastigmine, Galantamine and N-methyl D-aspartate receptor antagonist like Memantine. Many compounds are still under preclinical and clinical studies focusing on the pathology of Alzheimer's. The Recent studies target the formation and aggregation of amyloid plaques, inhibition of tau formation, stabilization of tau proteins, gene therapy and stem cell therapy. In this review summarises the current management and new approaches in the management of Alzheimer's disease.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tamilselvan, M., Tamilanban, T., & Chitra, V. (2020). Unfolding Remedial Targets for Alzheimer's Disease. Research Journal of Pharmacy and Technology, 13(6), 3021. https://doi.org/10.5958/0974-360x.2020.00534.x

MLA 9

Tamilselvan, M., et al. “Unfolding Remedial Targets for Alzheimer's Disease.” Research Journal of Pharmacy and Technology, vol. 13, no. 6, 2020, p. 3021. https://doi.org/10.5958/0974-360x.2020.00534.x.

Chicago

Tamilselvan, M., T. Tamilanban, and V. Chitra. 2020. “Unfolding Remedial Targets for Alzheimer's Disease.” Research Journal of Pharmacy and Technology 13 (6): 3021. https://doi.org/10.5958/0974-360x.2020.00534.x.

Harvard

Tamilselvan, M., Tamilanban, T. and Chitra, V. (2020) ‘Unfolding Remedial Targets for Alzheimer's Disease’, Research Journal of Pharmacy and Technology, 13(6), p. 3021. doi:10.5958/0974-360x.2020.00534.x.

IEEE

M. Tamilselvan, T. Tamilanban, and V. Chitra, “Unfolding Remedial Targets for Alzheimer's Disease,” Research Journal of Pharmacy and Technology, vol. 13, no. 6, p. 3021, 2020, doi: 10.5958/0974-360x.2020.00534.x.

BibTeX

@article{tamilselvan2020unfolding,
  title     = {{Unfolding Remedial Targets for Alzheimer's Disease}},
  author    = {Tamilselvan, M. and Tamilanban, T. and Chitra, V.},
  journal   = {Research Journal of Pharmacy and Technology},
  year      = {2020},
  volume    = {13},
  number    = {6},
  pages     = {3021},
  doi       = {10.5958/0974-360x.2020.00534.x},
  url       = {https://doi.org/10.5958/0974-360x.2020.00534.x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202233
202422
202544
202611

Its field-weighted citation impact is 0.27: it has been cited 0.27 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • dementia
  • amyloid plaques
  • neurofibrillary tangles
  • cholinergic deficit
  • early-onset Alzheimer's disease
  • late-onset Alzheimer's disease
  • amyloid precursor protein

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Tamilselvan, M., Tamilanban, T., & Chitra, V. (2020). Unfolding Remedial Targets for Alzheimer's Disease. Research Journal of Pharmacy and Technology, 13(6), 3021. https://doi.org/10.5958/0974-360x.2020.00534.x

How many times has this paper been cited?

10 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Research Journal of Pharmacy and Technology.

Who wrote this paper?

M. Tamilselvan, T. Tamilanban, V. Chitra.

What is the DOI of this paper?

10.5958/0974-360x.2020.00534.x. The permanent link is https://doi.org/10.5958/0974-360x.2020.00534.x.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.